Evidence map›Paper›PMID 36074434›Full record

ArticleJournal of applied oral science : revista FOB2022

Ginsenoside Rd inhibits migration and invasion of tongue cancer cells through H19/miR-675-5p/CDH1 axis.

Lu Chang, Dongxu Wang, Shaoning Kan, Ming Hao, Huimin Liu, Zhijing Yang, Qianyun Xia, Weiwei Liu

Open access · diamondAbstract read
In one paragraph

Article in Journal of applied oral science : revista FOB, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Cells · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Lu ChangJilin University, Hospital of Stomatology, Department of Oral and Maxillofacial Surgery, Changchun, China.ORCID http://orcid.org/0000-0002-3137-3606
Dongxu WangJilin University, College of Animal Science, Laboratory Animal Center, Changchun, China.ORCID http://orcid.org/0000-0003-0464-1596
Shaoning KanJilin University, Hospital of Stomatology, Department of Oral and Maxillofacial Surgery, Changchun, China.
Ming HaoJilin University, Hospital of Stomatology, Department of Oral and Maxillofacial Surgery, Changchun, China.
Huimin LiuJilin University, Hospital of Stomatology, Department of Oral and Maxillofacial Surgery, Changchun, China.
Zhijing YangJilin University, Hospital of Stomatology, Department of Oral and Maxillofacial Surgery, Changchun, China.
Qianyun XiaJilin University, College of Animal Science, Laboratory Animal Center, Changchun, China.
Weiwei LiuJilin University, Hospital of Stomatology, Department of Oral and Maxillofacial Surgery, Changchun, China.
Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTongue squamous cell carcinoma (TSCC) is an oral cancer, with high malignancy and frequent early migration and invasion. Only a few drugs can treat tongue cancer. Ginsenoside Rd is a ginseng extract with anti-cancer effects. Many noncoding RNAs are abnormally expressed in tongue cancer, thus influencing its occurrence and development. H19 and miR-675-5p can promote cancer cell growth. This study aimed to analyze the regulation effect of ginsenoside Rd on H19 and miR-675-5p in tongue cancer. METHODOLOGY: We used CCK8 and flow cytometry to study the growth and apoptosis. Transwell assay was used to assess invasion; wound-healing assay to assess migration; and colony formation assays to test the ability of cells to form colonies. H19, miR-675-5p, and CDH1 expressions were analyzed by qPCR. E-cadherin expression was detected using western blot. CRISPR/cas9 system was used for CDH1 knockout.

resultsGinsenoside Rd inhibited the growth and increased the apoptosis of SCC9 cells. Ginsenoside Rd also inhibited the migration and invasion of SCC9 cells. H19 and miR-675-5p were highly expressed, while CDH1 and E-cadherin expressions were low. H19 and miR-675-5p promoted SCC9 metastasis. In contrast, CDH1 and E-cadherin inhibited the metastasis of SCC9 cells. Bioinformatics analysis showed that miR-675-5p was associated with CDH1. H19 and miR-675-5p expressions decreased after ginsenoside Rd treatment, while CDH1 and E-cadherin expressions increased.

conclusionsGinsenoside Rd inhibits tongue cancer cell migration and invasion via the H19/miR-675-5p/CDH1 axis.

Indexed as

Carcinoma, Squamous CellMicroRNAsRNA, Long NoncodingTongue NeoplasmsAntigens, CDCadherinsCell Line, TumorCell MovementCell ProliferationGinsenosidesHistonesHumansTongueAntigens, CDCadherinsCDH1 protein, humanginsenoside RdGinsenosidesHistonesMicroRNAsMIRN675 microRNA, humanRNA, Long Noncoding

Identifiers

PMID36074434
PMCPMC9444189
OpenAlexW4294608872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.